Physician profile
Scott Michael Graham
NPI 1902809551
$878,258.09
in general payments reported to CMS, 2019-2025
16 companies · $31.98 in 2025
The $31.98 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $776K · 2021: $40.37 · 2022: $102K · 2023: $34.86 · 2024: $28.87 · 2025: $31.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $877,543.78 | 2020-2022 | |
| Stryker Corporation | $188.82 | 2019 | |
| Depuy Synthes Sales INC. | $133.51 | 2019 | |
| Zimmer Biomet Holdings, INC. | $99.64 | 2019-2020 | |
| Bioventus LLC | $67.61 | 2019-2020 | |
| Djo, LLC | $45.12 | 2021-2024 | Aircast |
| Pacira Therapeutics, INC. | $43.06 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $31.98 | 2025 | Exparel |
| Linvatec Corporation | $30.69 | 2019 | |
| Illuminoss Medical, INC. | $19.77 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Ferring Pharmaceuticals INC. | $16.80 | 2021 | |
| Smith+Nephew, INC. | $15.09 | 2023 | Panta 2 |
| Horizon Therapeutics Plc | $14.90 | 2019 | |
| Argentum Medical | $7.32 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,329,088.34 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.